These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25657071)

  • 1. Galactosylated poly(ethyleneglycol)-lithocholic Acid selectively kills hepatoma cells, while sparing normal liver cells.
    Gankhuyag N; Singh B; Maharjan S; Choi YJ; Cho CS; Cho MH
    Macromol Biosci; 2015 Jun; 15(6):777-87. PubMed ID: 25657071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with doxorubicin-loaded galactosylated poly(ethyleneglycol)-lithocholic acid to suppress the tumor growth in an orthotopic mouse model of liver cancer.
    Singh B; Jang Y; Maharjan S; Kim HJ; Lee AY; Kim S; Gankhuyag N; Yang MS; Choi YJ; Cho MH; Cho CS
    Biomaterials; 2017 Feb; 116():130-144. PubMed ID: 27914985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs.
    Chen W; Zou Y; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
    Biomacromolecules; 2014 Mar; 15(3):900-7. PubMed ID: 24460130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactions.
    Ding J; Xiao C; Li Y; Cheng Y; Wang N; He C; Zhuang X; Zhu X; Chen X
    J Control Release; 2013 Aug; 169(3):193-203. PubMed ID: 23247039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    Nasr M; Nafee N; Saad H; Kazem A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
    Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
    Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting the bioengineering versatility of lactobionic acid in targeted nanosystems and biomaterials.
    Alonso S
    J Control Release; 2018 Oct; 287():216-234. PubMed ID: 30149049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
    Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenoprotein Genes Exhibit Differential Expression Patterns Between Hepatoma HepG2 and Normal Hepatocytes LO2 Cell Lines.
    Zhao H; Tang J; Xu J; Cao L; Jia G; Long D; Liu G; Chen X; Wang K
    Biol Trace Elem Res; 2015 Oct; 167(2):236-41. PubMed ID: 25846212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactose-Modified PH-Sensitive Niosomes for Controlled Release and Hepatocellular Carcinoma Target Delivery of Tanshinone IIA.
    Hu X; Zhang J; Deng L; Hu H; Hu J; Zheng G
    AAPS PharmSciTech; 2021 Mar; 22(3):96. PubMed ID: 33694067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
    BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro.
    Nie C; Liu C; Chen G; Dai J; Li H; Shuai X
    J Biomater Appl; 2011 Sep; 26(3):255-75. PubMed ID: 20511388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles.
    Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ
    Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells.
    Goldberg AA; Beach A; Davies GF; Harkness TA; Leblanc A; Titorenko VI
    Oncotarget; 2011 Oct; 2(10):761-82. PubMed ID: 21992775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cells.
    Garg M; Madan J; Pandey RS; Sardana S; Katyal A; Chandra R
    Anticancer Drugs; 2012 Sep; 23(8):836-45. PubMed ID: 22407250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel galactose functionalized gold nanoparticles and its radiosensitizing mechanism.
    Zhu CD; Zheng Q; Wang LX; Xu HF; Tong JL; Zhang QA; Wan Y; Wu JQ
    J Nanobiotechnology; 2015 Oct; 13():67. PubMed ID: 26452535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled drug delivery systems. Part 6: in vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies.
    Jin Y; Lian Y; Du L; Wang S; Su C; Gao C
    Int J Pharm; 2012 Jul; 430(1-2):276-81. PubMed ID: 22486963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible protective role of pregnenolone-16 alpha-carbonitrile in lithocholic acid-induced hepatotoxicity through enhanced hepatic lipogenesis.
    Miyata M; Nomoto M; Sotodate F; Mizuki T; Hori W; Nagayasu M; Yokokawa S; Ninomiya S; Yamazoe Y
    Eur J Pharmacol; 2010 Jun; 636(1-3):145-54. PubMed ID: 20359477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumor growth in H-ras12V liver cancer mice by delivery of programmed cell death protein 4 using galactosylated poly(ethylene glycol)-chitosan-graft-spermine.
    Kim JH; Minai-Tehrani A; Kim YK; Shin JY; Hong SH; Kim HJ; Lee HD; Chang SH; Yu KN; Bang YB; Cho CS; Yoon TJ; Yu DY; Jiang HL; Cho MH
    Biomaterials; 2012 Feb; 33(6):1894-902. PubMed ID: 22153867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results.
    Popielarski SR; Hu-Lieskovan S; French SW; Triche TJ; Davis ME
    Bioconjug Chem; 2005; 16(5):1071-80. PubMed ID: 16173782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.